Caitlin Cronin
Stock Analyst at Canaccord Genuity
(4.70)
# 168
Out of 4,732 analysts
18
Total ratings
71.43%
Success rate
29.65%
Average return
Main Sectors:
Stocks Rated by Caitlin Cronin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VCEL Vericel | Maintains: Buy | $60 | $59.07 | +1.57% | 2 | Nov 19, 2024 | |
| KRMD KORU Medical Systems | Maintains: Buy | $3 → $4 | $4.09 | -2.20% | 2 | Nov 14, 2024 | |
| TELA TELA Bio | Maintains: Buy | $12 | $2.69 | +346.10% | 3 | Oct 4, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $20 | $11.57 | +72.86% | 3 | Aug 30, 2024 | |
| INMD InMode | Maintains: Hold | $21 → $16 | $16.79 | -4.71% | 2 | Jul 12, 2024 | |
| AXGN Axogen | Reiterates: Buy | $15 | $18.09 | -17.08% | 2 | Jun 20, 2024 | |
| ZBH Zimmer Biomet Holdings | Reiterates: Hold | $130 | $109.56 | +18.66% | 1 | Feb 23, 2024 | |
| ENOV Enovis | Maintains: Buy | $73 → $75 | $46.63 | +60.84% | 1 | Feb 23, 2024 | |
| GMED Globus Medical | Reiterates: Buy | $79 | $90.80 | -13.00% | 1 | Feb 21, 2024 | |
| RBOT Vicarious Surgical | Downgrades: Hold | $270 → $12 | $15.85 | -24.29% | 1 | Nov 14, 2023 |
Vericel
Nov 19, 2024
Maintains: Buy
Price Target: $60
Current: $59.07
Upside: +1.57%
KORU Medical Systems
Nov 14, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $4.09
Upside: -2.20%
TELA Bio
Oct 4, 2024
Maintains: Buy
Price Target: $12
Current: $2.69
Upside: +346.10%
Alphatec Holdings
Aug 30, 2024
Maintains: Buy
Price Target: $20
Current: $11.57
Upside: +72.86%
InMode
Jul 12, 2024
Maintains: Hold
Price Target: $21 → $16
Current: $16.79
Upside: -4.71%
Axogen
Jun 20, 2024
Reiterates: Buy
Price Target: $15
Current: $18.09
Upside: -17.08%
Zimmer Biomet Holdings
Feb 23, 2024
Reiterates: Hold
Price Target: $130
Current: $109.56
Upside: +18.66%
Enovis
Feb 23, 2024
Maintains: Buy
Price Target: $73 → $75
Current: $46.63
Upside: +60.84%
Globus Medical
Feb 21, 2024
Reiterates: Buy
Price Target: $79
Current: $90.80
Upside: -13.00%
Vicarious Surgical
Nov 14, 2023
Downgrades: Hold
Price Target: $270 → $12
Current: $15.85
Upside: -24.29%